FEATURE ARTICLES
Shutting down an operating biologics facility upsets systems often designed for continuous operation. One expert shares his tips for preventing unnecessary problems.
- Does The FDA's Plausible Mechanism Pathway Revolutionize The Way All Risks Are Analyzed?
- EMA's New Guideline For Synthetic Peptides: A More Explicit CMC Playbook For A Growing Therapeutic Class
- Hormuz Deal Brings Cautious Relief To Pharma Packaging Supply Chains
- Building PFMs For Scalable Manufacturing
- Is Your AI Model Trustworthy And Credible In GMP Processes?
- May 2026 — CDMO Opportunities And Threats Report
- Can Molecular Glue Degraders Make The Undruggable Druggable?
PHARMA ONLINE WHITE PAPERS
-
What Pharmacies Often Miss In USP <800> Compliance
Master USP <800> compliance by transitioning from standalone equipment to an integrated system design. Review key protocols for a multi-layered strategy to mitigate cumulative drug risks.
-
Criteria For Effective Bioprocess Scale-Up3/25/2026
Discover four essential bioprocess scale-up criteria and how each balances hydrodynamics, shear, and mass transfer across manufacturing scales.
-
Isolators For Pharmacy Compounding – Time For Change?3/14/2025
Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.
-
Don't Let Formulation Failures Derail Drug Development3/13/2026
In the face of increasing molecular complexity, early developability assessment with a skilled CDMO can reduce pharmaceutical development costs, prevent clinical delays, and improve commercial success.
-
Modern Containment Solutions In OSD Processes6/15/2026
Outdated containment infrastructure in OSD facilities creates costly compliance gaps and operational bottlenecks. Flexible single-use isolator systems offer a faster, more adaptable path forward.
-
Make Your Production Sites Adaptable And More Efficient12/12/2025
Pharma faces mounting complexity and tighter margins, demanding agile, future-ready production. Discover how smart manufacturing enables faster adaptation and continuous therapy availability.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Secondary Packaging: Labeling, Cartoning, Clamshell, And Stretch Carding
- Secondary Packaging: Cartoning And Kitting
- Secondary Packaging: Cartoning And Kitting With An Aggressive Timeline
- Secondary Packaging: Inspection, Brite Stock Bottle Labeling, And Cartoning
- Automation And Digital Solutions Can Help You Reach Your mRNA Manufacturing And Sustainability Goals
NEWSLETTER ARCHIVE
- 06.26.26 -- Can Molecular Glue Degraders Make The Undruggable Druggable?
- 06.25.26 -- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
- 06.25.26 -- STREAM Edition: Culture, Reporting And Education
- 06.24.26 -- Smarter risk management for single-use and filtration systems.
- 06.24.26 -- How Spray Drying Is Reshaping Modern Drug Development
INDUSTRY NEWS
-
Let Your Voice Help Shape Pharma Manufacturing
Pharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
ISPE Announces 2026 FOYA Winners
These awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
Høeg In, Pazdur Out At The FDA
What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
9 Drugs Granted Fast Track By FDA's Voucher Program
With targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
Leaders In The Excipient Market: Region And Type
Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Recipharm Invests In U.S. Fill-Finish Infrastructure To Accelerate Biologics Development6/17/2026
Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announced a multi-million-dollar investment in its US operations, strengthening its ability to support pharmaceutical and biotechnology companies with advanced sterile fill and finish services for biologics and advanced therapies.
-
Four Myths About Embedded CMOs, Busted6/17/2026
If you’re looking for a contract manufacturer to bring your therapy to market, you’re far from alone. Demand for manufacturing services is shaping the pharma Contract Manufacturing Industry, with analysts predicting a growth rate of nearly 7% per year until 2028.
-
Avoiding Recalls: How To Ensure Sterility In Ophthalmic Products6/17/2026
In the wake of several high-profile eye drop recalls, we look at the challenges of achieving sterility in ophthalmic products, the consequences of failing to do so, and how AbbVie Contract Manufacturing ensures product sterility and safety.
-
Veranova Appoints Dr. Bob Huang Vice President And General Manager Of West Deptford Site6/3/2026
Veranova today announced the appointment of Dr. Bob Huang as Vice President and General Manager for its West Deptford, New Jersey facility. He will lead site operations, advance strategic growth initiatives, and strengthen manufacturing excellence and customer delivery.